Taking Wegovy every other week: what actually happens to your treatment

Step 1: what semaglutide's pharmacokinetics actually mean for a fortnightly gap

Wegovy reaches a stable working concentration in the blood after roughly four to five weeks of once-weekly injections. That steady state is the therapeutic sweet spot: appetite signals are blunted, gastric emptying is slowed, and calorie intake tends to fall naturally. Semaglutide's half-life of around seven days means that one week after an injection, approximately half of the active drug has already cleared. By week two, the concentration has fallen to roughly a quarter of its peak.

Spread your doses a fortnight apart and you never sustain a meaningful steady state. Instead, you get a sawtooth pattern: a peak after each injection, then a steep drop before the next one. In practical terms, that drop often shows up as a return of hunger, food noise and cravings in the days before the next dose is due. Many people taking Wegovy every other week report feeling as though they are starting from scratch each time rather than building on progress.

The STEP 1 trial published in the New England Journal of Medicine studied semaglutide 2.4mg on a strict once-weekly schedule over 68 weeks and found an average body-weight reduction of around 15%. There are no equivalent trial data for a fortnightly schedule. Extrapolating from pharmacokinetic principles, the reduced exposure would be expected to produce meaningfully less weight loss.

Step 2: the specific things that change when the dose gap widens

Appetite suppression is the first thing to weaken. GLP-1 receptors in the brain's hypothalamus play a central role in signalling fullness; sustained receptor activation requires sustained drug levels. When those levels fall into a trough, the signal fades, portion sizes tend to creep up, and high-calorie foods become harder to resist.

Gastric emptying speeds back up too. One of Wegovy's mechanisms is slowing the rate at which food leaves the stomach, which prolongs the feeling of fullness after eating. A significant concentration drop partway through a fortnightly cycle removes that effect. You might notice you feel hungry sooner after meals in the second week of a gap.

There is also the question of titration. The licensed schedule starts at 0.25mg and steps up roughly every four weeks. That gradual increase is designed to let the body adjust and reduce gastrointestinal side effects. If you are spacing doses out and therefore receiving less total semaglutide over time, your prescriber's dose-escalation decisions (based on clinical review of your response) may no longer reflect what your body is actually receiving. The NHS medicines guidance on semaglutide is clear that the schedule should be followed as directed and that any questions about changing it belong with the prescriber or pharmacist.

Step 3: when and how to raise this with your prescriber

The most common reason people consider spacing doses out is side effects, nausea, vomiting, or fatigue that feels too disruptive to manage on a weekly cycle. That is a real and legitimate concern, and there are licensed ways to address it. Slowing the titration pace (staying on a lower dose for longer before stepping up) is an approach prescribers often use. A dose reduction, at least temporarily, is another option.

What matters is that these adjustments happen with clinical oversight, not around it. If you have already missed a dose and are wondering how to get back on track, the guidance on what to do after a missed Wegovy dose covers the practical steps clearly. The short answer: if your next scheduled dose is more than five days away, take the missed dose as soon as you remember; if fewer than five days remain, skip it and resume your usual day. Do not take two doses to compensate.

Keep your pen in a consistent spot (a lot of people use the fridge door) and set a recurring phone reminder for the same day each week. Routine is one of the most reliable ways to avoid accidental gaps. If side effects are making that weekly routine difficult to sustain, a conversation with our prescribers is the right next move. If you want a fuller picture of what happens when you take Wegovy, including how it works in your body from the first dose onwards, that page is a useful place to start. You can also read about what happens if you take semaglutide twice a week to understand why the frequency matters in both directions, or review the cost context if you are thinking about the practicalities of ongoing treatment on the Wegovy UK cost page.

For completeness: deliberately taking semaglutide more frequently than once weekly carries different risks, and it is worth understanding what happens if you take too much Wegovy, since exceeding the recommended dose increases the risk of side effects without adding clinical benefit. If you are unsure about timing and want to know more about what happens if you take Wegovy too soon, that page explains why leaving the correct interval between doses matters for both safety and effectiveness. The licensed schedule is once weekly for good reason in both directions.

If you are considering starting Wegovy or have questions about how to make your current treatment work better for you, a free consultation with a GPhC-registered prescriber at our treatment page is the right place to start.